Home
This site is intended for healthcare professionals

Latest Updates in Cancer Cachexia Diagnosis & Management 2025

22nd Sep 2025
1:30 - 2:15pm (GMT)
22nd Sep 2025
1:30 - 2:15pm (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
Online

Description

This program is supported by an independent education grant from Pfizer Global Medical Grants. This online education program has been designed for healthcare professionals globally.

In this online teaching session, leading expert Dr. Barry Laird, MD delves into the early recognition, diagnosis, and multimodal management of cancer cachexia. Dr. Laird will review validated diagnostic frameworks (e.g., ≥5% unintentional weight loss, low BMI, sarcopenia), demonstrate practical bedside assessment tools such as handgrip strength and mid-arm circumference, and outline evidence-based strategies to support appetite, preserve lean body mass, and maintain physical function in patients with cancer cachexia.

Accreditation: 0.75 AMA PRA Category 1 Credit™

Session Highlights

  • Early Recognition Frameworks: Apply cancer-specific diagnostic criteria and objective tools to enable timely intervention in cachexia
  • Bedside Assessment Techniques: Integrate handgrip strength, mid-arm circumference, and EMR documentation into routine practice
  • Multimodal Management Approaches: Coordinate nutritional, exercise, and pharmacologic therapies tailored to individual patient needs

Who Should Watch

  • Medical Oncologists
  • Oncology Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists
  • Dietitians
  • Physiotherapists
  • Psychologists
  • Palliative Care Specialists
  • Internal Medicine Physicians with Oncology Focus

Presented by

Barry Laird, MD – is is an academic clinician in palliative medicine, with a research focus on how tumor–host interactions and systemic inflammation drive symptoms such as pain, cachexia, and fatigue in advanced cancer. Based within the Edinburgh Palliative and Supportive Care Group, his work aims to improve prognostication and symptom management through translational research. Clinically, he is a Consultant in Palliative Medicine at the Edinburgh Cancer Centre and St Columba’s Hospice.

Continuing Education Information

This continuing education activity will be provided by Current Concepts Institute (CCI) and MedAll. Physicians, Nurse Practitioners, and Physician Assistants will be eligible for AMA PRA Category 1 Credit™; Nurses for ANCC Contact Hours. A statement of participation is available for other healthcare professionals .

Unapproved and/or off-label use disclosure

Current Concepts Institute/MedAll requires CE faculty to disclose to the participants:

1. When products or procedures being discussed are off-label, unlabelled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and

2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Disclosures

Below is a listing of all individuals who are involved in the planning and implementation of this accredited continuing education activity. All relevant financial relationships listed for these individuals have been mitigated. These disclosures are made in accordance with ACCME standards to ensure transparency and objectivity in continuing education.

Dr. Barry J. A. Laird has disclosed financial relationships within the past 24 months with the following ineligible companies: Artelo, Endevica Bio, Pfizer, Catalym, and Abbott, serving in advisory or investigator roles. He does not intend to reference any unlabeled or unapproved uses of products during the presentation

CCI staff, MedAll staff, and all planners and reviewers have no relevant financial relationships with ineligible companies to disclose.

Activity Accreditation for Health Professions

Physicians

AMA PRA Category 1 Credits™ are available for this activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Current Concepts Institute and MedAll Education. Current Concepts Institute is accredited by the ACCME to provide continuing medical education for physicians.

Current Concepts Institute designates this online activity a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing education activity is active starting 22nd September 2025 and will expire on 22nd September 2025. Estimated time to complete this activity: 45 minutes

Other Professionals

All other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity.

Participation Costs

There is no cost to participate in this program.

Learning objectives

Recognize and diagnose CC earlier and more consistently across cancer types:

  • Apply validated diagnostic frameworks (e.g., criteria including ≥5% weight loss, low BMI, sarcopenia) to identify cachexia in its early stages.
  • Integrate practical bedside tools (e.g., handgrip strength, mid-arm circumference) and EMR-based documentation practices into routine assessments.
  • Identify and overcome barriers to cachexia screening, including patient communication concerns and inconsistent team workflows.

Implement evidence-based, multimodal strategies to support appetite, lean body mass, and physical function in patients with CC:

  • Coordinate multidisciplinary care that combines nutritional interventions, physical activity programs, and pharmacologic therapies tailored to patient status.
  • Engage dietitians, physiotherapists, and palliative care teams to deliver individualized, stage-appropriate cachexia management.
  • Monitor intervention outcomes through functional measures (e.g., muscle mass, mobility) and adjust care plans accordingly.
View all

Similar events and on demand videos

 
22nd Sep 2025
1:30 - 2:15pm (GMT)
Hosted on MedAll
Attendance certificate available
This event has ended. Similar events
Free
Online